Icahn School of Medicine at Mount Sinai

11/30/2025

Thank you to everyone who joined us for the 3rd Annual Women’s Health Forum at the New York Academy of Medicine. This year’s full-day program brought together clinicians, researchers, trainees, and community members for a comprehensive exploration of menopause and women’s health beyond midlife.

Special thanks to our Health Forum co-directors Susan Khalil, MD, and Joanne Stone, MD, MS (OBGYN Chair), along with our featured speakers—Anna Barbieri, MD; Susan Khalil, MD; Joanne Stone, MD, MS; Lisa Ellis, MS, RDN; and Francesco Callipari, MD—for leading insightful, evidence-based discussions throughout the day.

Sessions covered perimenopause and menopause, mental and hormonal wellness, sexual health, and integrative approaches to long-term wellbeing. Attendees also explored how AI, imaging, and genetics are transforming diagnostics and shaping the future of personalized care.

We are grateful to our faculty, partners, and participants for contributing to a dynamic and impactful event—and for helping advance women’s health for all.

11/25/2025

Congratulations to Varun Kumar, PhD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, on receiving a Cornea Research Foundation of America Pilot Grant to advance his groundbreaking research on Fuchs’ endothelial corneal dystrophy; a condition that affects nearly 4% of Americans.

This award recognizes Dr. Kumar’s exceptional promise as an early-career investigator working to uncover new insights into the causes and treatments of this vision-threatening disease.

11/25/2025

We are proud to mark the 10-year anniversary of the International School of Immunotherapy (Immunoschool), a virtual global education initiative founded by Miriam Merad, MD, PhD. What began as a three-country pilot in partnership with leading immunologists from Sorbonne Université and the USP - Universidade de São Paulo has expanded to reach more than 2,000 learners across 82 countries.

The Immunoschool’s mission is to equip clinicians and basic scientists with the knowledge to harness the immune system for effective disease prevention and treatment. Learn how this unique program is shaping the future of immunotherapy and training the next generation of scientific leaders: https://mshs.co/3K7Gu4U

11/23/2025

Alon Harris, MS, PhD, FARVO has been appointed the Interim Director of The Barry Family Center for Ophthalmic Artificial Intelligence and Human Health at the Icahn School of Medicine at Mount Sinai.

The Center’s clinical programs are focused on equitable, primary care-based vision care, and it supports research aimed at the early diagnosis of eye diseases and the creation of innovative risk assessments of systemic health conditions linked to eye disorders.

11/21/2025

Congratulations to Roxana Mehran, FACC, FAHA, FESC, MSCAI, on receiving the prestigious 2025 Laennec Master Clinician Award from the American Heart Association’s Council on Clinical Cardiology. This honor recognizes Dr. Mehran’s individual lifetime achievements in patient care and cardiology education and her exceptional insight in correlating the pathophysiology of cardiovascular disease with clinical findings at the bedside.

“This award is deeply meaningful to me because it recognizes what has always been at the heart of my career—bridging science and clinical care. Teaching and mentoring the next generation of cardiologists, while bringing the latest scientific insights directly to patients, has been one of the greatest privileges of my professional life. The true essence of medicine lies in that connection between discovery, knowledge, and compassionate care,” said Dr. Mehran

Read more: https://mshs.co/4hYwDKV

11/20/2025

New cell therapies are opening the door to treating age-related macular degeneration beyond the small group helped by current antibody options. Associate Professor of Ophthalmology Dr. Timothy Blenkinsop explains how eye donations through the Eye-Bank of New York are helping power promising clinical trials that expand hope to so many more patients.

To learn more about and donor registration: https://mshs.co/3V4trl8

11/19/2025

The Icahn School of Medicine at Mount Sinai and ARC Innovation at Sheba Medical Center have entered a transformative three-year partnership with NVIDIA to advance genomic discovery using artificial intelligence and large language model (LLM) technology.

This collaboration aims to decode the 98 percent of the human genome that remains insufficiently understood, creating new opportunities for disease prevention, diagnosis, and precision treatment. By combining Mount Sinai and Sheba’s extensive genomic expertise and clinical insight with NVIDIA’s cutting-edge computational architecture and AI platforms, the partnership will support the development of a state-of-the-art Genomic Foundation Model.

The initiative will function as a unified global engine for scientific discovery, integrating genomics, data science, and AI-driven clinical innovation to accelerate breakthroughs with the potential to benefit patients worldwide.

Read more about our exciting path forward here: https://mshs.co/4pomcTM

From left to right, first row: Michael Kagan, CTO, NVIDIA; Professor Yitshak Kreiss, Director General Sheba Medical Center; Dr. Alexander Charney, Director, Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai. Second row: Avner Halperin, ARC; Professor Gidi Rechavi, Sheba Medical Center; Dr. Yoli Shavit, NVIDIA; Professor Eyal Zimlichman, ARC; Dr. Nati Daniel, NVIDIA. Photo credit: Sheba Medical Center.

11/18/2025

Researchers at the Icahn School of Medicine at Mount Sinai, the CUNY Graduate School of Public Health & Health Policy, and Weill Cornell Medicine are launching an innovative clinical trial that integrates nutrition directly into the treatment of metabolic liver disease. The program will provide medically tailored meals to patients with metabolic dysfunction-associated steatohepatitis (MASH) who are receiving new drug therapies, aiming to make behavioral lifestyle changes more achievable and sustainable.

Led by Drs. Xiaotao (Rony) Zhang, Meena Bansal, and Jeffrey Lazarus, the study represents a novel “food is medicine” approach that addresses both clinical and social determinants of health. By combining nutritional intervention with pharmacologic therapy, the trial seeks to improve outcomes, enhance treatment efficacy, and reduce health disparities related to diet and access to care.

Read more in the Specialty Report: https://mshs.co/4obq0Xv

11/17/2025

We are proud to share that Miriam Merad, MD, PhD—Dean for Translational Research and Therapeutic Innovation, Chair of the Department of Immunology and Immunotherapy, and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute—has been elected a Fellow of the Accademia Nazionale dei Lincei, Italy’s most historic and prestigious scientific academy.

Dr. Merad is one of just 46 researchers worldwide selected for induction in 2025. This honor recognizes her groundbreaking contributions to immunology, including pioneering discoveries that have reshaped our understanding of macrophages, dendritic cells, and the innate immune system in cancer, inflammation, and tissue repair.

Her election to the Lincei Fellowship marks another exceptional achievement in a year of major honors, including the Chevalier de la Légion d’honneur from the French government and the Sjöberg Prize from the Royal Swedish Academy of Sciences.

Read more about this accomplishment here: https://mshs.co/486bhXP

11/14/2025

We’re proud to congratulate Aditya Shekhar on receiving ’s Early Career Investigator Award in Resuscitation Science, honoring his impactful research advancing the science of cardiac resuscitation.

11/14/2025

We’re proud to congratulate Aditya Shekhar on receiving the American Heart Association's Early Career Investigator Award in Resuscitation Science, honoring his impactful research advancing the science of cardiac resuscitation.

11/13/2025

Following the COVID-19 pandemic, Rabbi Edith Meyerson, DMin, BCC, and Sasha Perez, MPH, led a listening campaign at the Brookdale Department of Geriatrics and Palliative Medicine to hear staff concerns and identify opportunities for growth. Their Community Building program now fosters connection, mentorship, collaboration, and wellness—creating a more supportive and engaged workplace for clinicians, researchers, and staff.

Read more about their compassionate work here:

TK